Vipin K. Garg - Feb 1, 2024 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
President and CEO, Director
Signature
/s/ Richard I. Eisenstadt, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Feb 1, 2024
Transactions value $
-$150,317
Form type
4
Date filed
2/5/2024, 06:00 PM
Previous filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Options Exercise $0 +16.5K +6.08% $0.00 289K Feb 1, 2024 Direct F1
transaction ALT Common Stock, par value $0.0001 Tax liability -$72.3K -7.31K -2.53% $9.88 281K Feb 1, 2024 Direct F2
transaction ALT Common Stock, par value $0.0001 Options Exercise $0 +19K +6.73% $0.00 300K Feb 2, 2024 Direct F1
transaction ALT Common Stock, par value $0.0001 Tax liability -$78.1K -8.38K -2.79% $9.32 292K Feb 2, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Restricted Stock Units Options Exercise $0 -16.5K -50% $0.00 16.5K Feb 1, 2024 Common Stock, par value $0.0001 16.5K Direct F1, F3
transaction ALT Restricted Stock Units Options Exercise $0 -19K -33.33% $0.00 37.9K Feb 2, 2024 Common Stock, par value $0.0001 19K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
F2 Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
F3 The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date
F4 The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.